Our firm has represented clients in class action suits against the manufacturers of such injury-causing drugs as Rezulin®, Propulsid®, Celebrex®, Vioxx® and Fen-Phen. Today, drug manufacturers Pfizer, Inc. and Merck & Company may be held liable for marketing potentially dangerous products. Our Ohio lawyer, attorney H. Lee Thompson, is currently accepting new clients from across the nation who have sustained permanent injuries as a result of using these dangerous drugs.

If you or someone you know underwent open heart surgery and had kidney problems (with or without dialysis) soon afterward, usually during the same hospitalization when the heart surgery was done, please contact The Thompson Law Firm’s defective drug attorney, H. Lee Thompson today.

Drug Injuries Are Preventable
Did You Suffer an Injury from A Prescription Drug?
Injured from a Dangerous Drug?
Get Compensation For Your Drug Related Injury

Should you or someone you know experience problems or complications with the following, please contact The Thompson Law Firm’s medical device attorney, H. Lee Thompson for a consultation.

Transvaginal Mesh

Bladder Sling

Pelvic Mesh

Xarelto

Power Morcellator

Benicar

Metal-on-Metal Hip Implant

Gadolinium

Gadolinium based contrast agents are often used to enhance the quality of MRIs. However, recent investigations have discovered a link between the use of gadolinium based contrast agents and the development of a rare, debilitating disease called Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD). NSF involves the fibrosis or stiffening and swelling of the skin, joints, internal organs, and other body parts. The disease can also cause discolored, irritated patches of skin. There is no known cure for this potentially fatal disease. The development of NSF/NSD is especially common among patients who have suffered previous kidney problems.

NSF was first identified in 1997, around the same time that the use of gadolinium based contrast agents was becoming more common. The risks associated with these products were known to the manufacturers. By May of 2007 the FDA issued a statement requesting that all manufacturers of gadolinium based dyes used in MRI’s include a warning on their product.

There are currently five gadolinium based contrast agents on the market. They are Magnevist (gadopentetate dimeglumine), Omniscan (gadodiamide), OptiMARK (gadoversetamide), MultiHance (gadobenate dimeglumine), and Prohance (gadoteridol). If you or someone you know has developed Nephrogenic Systemic Fibrosis as a result of being exposed to any of these products, contact our defective drug attorney H. Lee Thompson.